Corvus pharmaceuticals, inc. (CRVS)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15
Operating expenses:
Research and development

38,719

37,975

37,449

36,827

35,902

38,586

39,881

42,240

44,911

46,305

45,749

42,723

37,456

29,356

25,132

19,939

14,825

11,352

0

0

0

General and administrative

11,099

10,879

11,136

11,394

10,981

10,636

10,359

9,795

10,040

10,219

9,835

10,393

9,311

7,620

6,699

4,536

3,157

2,418

0

0

0

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

0

-

-

Total operating expenses

49,818

48,854

48,585

48,221

46,883

49,222

50,995

55,020

0

-

0

0

-

-

-

-

-

-

-

0

0

Loss from operations

-49,818

-48,854

-48,585

-48,221

-46,883

-49,222

-50,240

-52,035

-54,951

-56,524

-55,584

-53,116

-46,767

-36,976

-31,831

-24,475

-17,982

-13,770

0

0

0

Change in fair value of convertible preferred stock liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,600

0

0

0

Interest income and other expense, net

1,854

2,182

2,451

2,593

2,602

2,283

1,848

1,390

0

-

0

0

-

-

-

-

-

-

0

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

0

0

Net loss

-47,964

-46,672

-46,134

-45,628

-44,281

-46,939

-48,359

-50,578

-53,928

-55,663

-54,820

-52,400

-46,064

-36,375

-31,328

-24,182

-35,769

-31,335

0

0

0

Net loss per share, basic and diluted (in dollars per share)

-0.44

-0.38

-0.37

-0.44

-0.40

-0.32

-0.36

-0.40

-0.63

-0.58

-0.62

-0.73

-0.79

3.97

-0.51

-0.43

-5.39

-11.03

-7.97

-58.42

-6.44

Shares used to compute net loss per share, basic and diluted (in shares)

29,411

29,408

29,389

29,309

29,292

29,392

29,087

28,979

22,580

20,676

20,501

20,426

20,349

20,368

20,183

19,959

1,176

455

395

346

297

Other comprehensive loss:
Unrealized gain on marketable securities

32

63

73

63

54

7

-26

27

19

-2

-55

-129

-91

6

88

0

0

-

0

-

-

Total other comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Comprehensive loss

-47,932

-46,609

-46,061

-45,565

-44,227

-46,932

-48,385

-50,551

-53,909

-55,665

-54,875

-52,529

-46,155

-36,369

-31,287

-24,104

-35,740

-31,380

0

0

0